This week Shaare Zedek Madait, the scientific arm of Shaare Zedek Medical Center announced a strategic partnership with Imagene AI to advance cancer research and patient care using artificial intelligence and real-world clinical data.

By combining Madait’s rich patient data with Imagene’s AI-powered Oncology Intelligence Suite, this partnership will help doctors and researchers:

Better understand cancer and its behavior

Discover new treatment targets

Make more personalised treatment decisions for patients

This collaboration is helping to bring truly personalised cancer care closer to reality, showing how science, technology, and compassion can work together to improve lives.

Pictured below from L-R Renana Ofan, CEO, Shaare Zedek Scientific, Professor Ofer Merin, Director General of Shaare Zedek Medical Center, Dean Bitan Co-Founder & CEO at Imagene and Prof. Dan Turner, Chairman, Board of Directors, Madait

Read the full announcement here